Is Time to Progression Associated With Post-Progression Survival in Previously Treated Metastatic Non-Small Cell Lung Cancer With BRAF V600E Mutation? A Secondary Analysis of Phase II Clinical Trial Data

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-021642
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Clinical Cancer Research
Cancer ResearchOncology
2010English

A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Cancer Management and Research
Oncology
2019English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Identification of Serum Proteome Components Associated With Progression of Non-Small Cell Lung Cancer.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2014English

Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2014English

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

PLoS ONE
Multidisciplinary
2011English

P3.01-05 Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

TP53 Mutation Is Associated With a Poor Clinical Outcome for Non-Small Cell Lung Cancer: Evidence From a Meta-Analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy